Summary
- Current Price
- As of today, GOSS price is $0.37, up +1.37% on
- Current Price All-Time High
- GOSS price is currently -98.64% below its historical high of $27.15 set on
- Market Cap
- GOSS current market cap is $86M, down -61.50% year-over-year
- PE Ratio
- GOSS PE ratio is unknown
- Revenue
- GOSS current annual revenue is $48.47M, down -57.74% year-over-year
- Next Earnings
- The next earnings release for GOSS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Gossamer Bio, Inc. |
| Ticker | NASDAQ: GOSS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gossamerbio.com |
| Employees | 144 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.37 | |
| Price, 1D Change | +1.37% | |
| $86M | ||
| - | ||
| - | ||
| 1.77 | ||
| $48M | ||
| Revenue, 1Y Change | -57.74% | |
| -$0.75 | ||
| EPS, 1Y Change | -198.32% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.75 | ||
| EPS Estimate | N/A | -$0.49 |
| EPS Est. Change | N/A | +34.41% |
| $48.47M | ||
| Revenue Estimate | N/A | $17.62M |
| Revenue Est. Change | N/A | -63.66% |
| Current Price | $0.37 | |
| Price Target | - | $1.00 |
| Price Tgt. Change | - | +170.27% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.28 | -$0.25 | +11.10% | |
| -$0.74 | -$0.75 | -0.55% | |
| -$0.49 | N/A | +34.41% | |
| -$0.17 | N/A | +77.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $112.19M | $114.70M | +2.24% | |
| $42.19M | $48.47M | +14.88% | |
| $17.62M | N/A | -63.66% | |
| $57.20M | N/A | +18.00% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.37 | |
| $2.16 | ||
| SMA 200 vs Price | +483.97% | |
| $1.26 | ||
| SMA 50 vs Price | +240.41% | |
| 1.77 | ||
| $0.08 | ||
| 28.63 | ||
| 126.38% | ||
| 123.73% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $48.47M | ||
| -$0.75 | ||
| $47.47M | ||
| 97.93% | ||
| -$163.25M | ||
| -336.81% | ||
| -$170.37M | ||
| -351.49% | ||
| -$162.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.65 | ||
| 2.64 | ||
| 2.64 | ||
| - | ||
| 1 | ||
| -13.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.77 | ||
| -0.70 | ||
| -0.93 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$122.76M | ||
| $136.93M | ||
| $172.25M | ||
| $167.64M | ||
| $295.01M | ||
| $63.44M | ||
| $202.91M | ||
| $938.00K | ||
| $5.96M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $218.84M | ||
| $210.72M | ||
| $1.00M | ||
| $0.00 | ||
| $1.00M | ||
| $0.00 | ||
| -$88.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$171.27M | ||
| $156.36M | ||
| $6.43M | ||
| $79.00K | ||
| -$171.35M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| Wedbush | → | |
| Leerink Partners | → | |
| Barclays | → | |
| Barclays | ||
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with GOSS
FAQ
What is the ticker symbol for Gossamer Bio, Inc.?
The ticker symbol for Gossamer Bio, Inc. is NASDAQ:GOSS
Does Gossamer Bio, Inc. pay dividends?
No, Gossamer Bio, Inc. does not pay dividends
What sector is Gossamer Bio, Inc. in?
Gossamer Bio, Inc. is in the Healthcare sector
What industry is Gossamer Bio, Inc. in?
Gossamer Bio, Inc. is in the Biotechnology industry
What country is Gossamer Bio, Inc. based in?
Gossamer Bio, Inc. is headquartered in United States
When did Gossamer Bio, Inc. go public?
Gossamer Bio, Inc. initial public offering (IPO) was on February 8, 2019
Is Gossamer Bio, Inc. in the S&P 500?
No, Gossamer Bio, Inc. is not included in the S&P 500 index
Is Gossamer Bio, Inc. in the NASDAQ 100?
No, Gossamer Bio, Inc. is not included in the NASDAQ 100 index
Is Gossamer Bio, Inc. in the Dow Jones?
No, Gossamer Bio, Inc. is not included in the Dow Jones index
When was Gossamer Bio, Inc. last earnings report?
Gossamer Bio, Inc.'s most recent earnings report was on November 5, 2025
When does Gossamer Bio, Inc. report earnings?
The next expected earnings date for Gossamer Bio, Inc. is May 14, 2026
Data Sources & References
- GOSS Official Website www.gossamerbio.com
- GOSS Profile on Yahoo Finance finance.yahoo.com/quote/GOSS
- GOSS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/goss